Propanc Biopharma PPCB Stock
Propanc Biopharma Price Chart
Propanc Biopharma PPCB Financial and Trading Overview
| Propanc Biopharma stock price | 6.46 USD |
| Previous Close | 0.11 USD |
| Open | 0.0002 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.11 - 0.11 USD |
| 52 Week Range | 0.02 - 7.05 USD |
| Volume | 225.7K USD |
| Avg. Volume | 88.95K USD |
| Market Cap | 360.74B USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -116.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PPCB Valuation Measures
| Enterprise Value | 67.72K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Propanc Biopharma Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -99.074% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.05 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.3 USD |
| 200-Day Moving Average | 0.74 USD |
PPCB Share Statistics
| Avg. Volume (3 month) | 88.95K USD |
| Avg. Daily Volume (10-Days) | 158.47K USD |
| Shares Outstanding | 1.76B |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0.67% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Propanc Biopharma
| Country | United States |
| State | VIC |
| City | Camberwell |
| Address | 302, 6 Butler Street |
| ZIP | 3124 |
| Phone | 61 3 9882 0780 |
| Website | https://www.propanc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.
Q&A For Propanc Biopharma Stock
What is a current PPCB stock price?
Propanc Biopharma PPCB stock price today per share is 6.46 USD.
How to purchase Propanc Biopharma stock?
You can buy PPCB shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Propanc Biopharma?
The stock symbol or ticker of Propanc Biopharma is PPCB.
Which industry does the Propanc Biopharma company belong to?
The Propanc Biopharma industry is Biotechnology.
How many shares does Propanc Biopharma have in circulation?
The max supply of Propanc Biopharma shares is 11.61M.
What is Propanc Biopharma Price to Earnings Ratio (PE Ratio)?
Propanc Biopharma PE Ratio is now.
What was Propanc Biopharma earnings per share over the trailing 12 months (TTM)?
Propanc Biopharma EPS is -116.19 USD over the trailing 12 months.
Which sector does the Propanc Biopharma company belong to?
The Propanc Biopharma sector is Healthcare.